Fact CheckerSign in

NCT07001267Recruiting

Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke

Source: ClinicalTrials.gov · Last updated 12 Mar 2026

Brief summary (registry, in English)

This study is being done to compare outcomes after surgery for individuals who receive anesthesia through by inhaling medication and individuals who receive anesthesia intravenously by needle when experiencing treatment for their stroke. Currently very little is known about the outcomes for patients when comparing these two techniques of providing anesthesia during surgery. This study will provide information regarding outcomes that will help health care providers decide which technique will be better for patients

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
23 May 2025
Start date
4 Jun 2025
Primary completion date
31 May 2027
Lead sponsor
University of Kansas Medical Center
Diseases
Stroke
NCT number
NCT07001267

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 4 Jun 2025 to the primary completion date, 31 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with malignant hyperthermia
  • Allergies or any contraindications to either inhalational or intravenous agents

Age

  • \<18 years

Other

  • Pregnant patients
  • Patients already on intravenous anesthetic infusions
  • Prisoners
  • Students and employees

Who the study is looking for

  • \>18 years Acute ischemic stroke requiring endovascular treatment.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kansas Medical Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.